Board of directors

Mr. Henri Harland

Mr. Henri Harland has been a Director and the President and Chief Executive Officer of the company since its incorporation on October 9, 1998. He is the founder of the company and has been involved in the krill research project since 1991. For more than 10 years, he has held the position of President and Chief Executive Officer of Groupe Conseil Harland inc., a financial engineering group. He has acted as an independent financial consultant, guiding companies from various industrial sectors in both North America and Europe in their capital restructuring, financing and business development.

Dr. Ronald Denis

Dr. Ronald Denis is currently Chief of Surgery and Co-Director of the Trauma Program at Hôpital du Sacré-Coeur in Montreal. Since 1987, Dr. Denis has also been Medical Co-Director of the Canadian Formula 1 Grand Prix. Dr. Denis sits on several scientific boards and management committees.

Mr. Daniel Perry

Since March 1993, Mr. Daniel Perry has been General Manager of a company operating a recreation/tourism complex in France. Also, Mr. Perry is a specialist and consultant in marketing new products on the European continent.

Mr. Michel Chartrand

Mr. Michel Chartrand is the Chief Operating Officer of the company. From July 2009 to July 2011, he was the Vice-President of Retail Partner Solutions at McKesson Canada. From 2004 to 2009, he was the President and Chief Executive Officer of Groupe PharmEssor inc., which regroups Gestion Santé Services Obonsoins inc. and Groupe Essaim inc., two large Quebec pharmacy franchises. From 1998 to 2004, Mr. Chartrand was the Executive Vice-President of Gestion Santé Services Obonsoins inc.

Mr. Jean-Claude Debard

Mr. Jean-Claude Debard has been President of Hyundai Automobile France and FEA Services, as well as an officer of Frey Accessories and Parts since 1999, and most recently, Executive President of Group Emil Frey France since 2008. Since 1999, Mr. Debard has sat on the boards of Surveillance Committees of Holding (SERGESA), SsangYong France and Hyundai Finances.

Dr. Harlan W. Waksal

Dr. Waksal is a retired physician. He is the Vice-President of Business and Scientific Affairs at Acasti Pharma Inc. He received his B.A. from Oberlin College and M.D. from Tufts University School of Medicine, and his post-graduate training was in internal medicine and pathology. He also accomplished research in immunology at the Weizmann Institute of Science. Dr. Waksal was a founder of ImClone Systems Incorporated, a New York based pharmaceutical company specializing in the development of new treatments for various forms of cancer. He served as the Chief Operating Officer and member of the Board of Directors from 1986 until 2001, and as President and Chief Executive Officer from 2001 until 2002. During his tenure, he was responsible for building the scientific and operational infrastructure of the company. Dr. Waksal is the author of over 50 scientific publications and has been the author of multiple patents and patent applications. His current activities are focused on managing various real estate developments and serving on select boards of directors. Dr. Waksal currently serves on the boards of Oberlin College and Senesco Technologies, Inc. He also serves on the Advisory Board of Northern Rivers Funds.